Max Noble
Menu
CEO Storm Watch · the report20 October 2026

Max Noble

Embla Medical

Sveinn Sölvason promised 5–8% sales growth. Delivered: about 5%.

🇩🇰 Denmark · Prosthetics and orthoticsEmbla0.0IntegritySveinn SölvasonSveinn SölvasonPresident & CEO, Embla MedicalPromisedSales growth, 20265–8%3 February 2026

Last checked · How I check · Follow this CEO

He promised

5–8% more sales

Sveinn Sölvason, President & CEO, on 3 February 2026.

He got

About 5%

Stamp: Partly kept.

Why, says the company

Its clinics sold less than planned, and it lost a contract in Sweden. The profit promise held.

How bad

Big miss. Only the bottom of the promise, after three cuts. The CEO’s Integrity Score went from 0.0 to +4.4.

In the company’s own words

Patient Care sales were below the expectations set at the start of the year, slowed by integration work in its clinics and a lost regional tender in Sweden. The margin promise held, helped by cost control.

The sources

Last checked 1 November 2026: the sources were opened again and the promise and the stamp still stand. How I check.

How the Max Noble Odds moved

Odds: 55% before the first call → verdict on 2 February 2027

The chance of Yes to “Will Embla grow its sales by about 5% in 2026, as promised?” The first number is my starting estimate; every call moves it. One point a day is kept from 8 November 2026 to the verdict.

Will Embla grow its sales by about 5% in 2026, as promised? Make your call in The Power Game →

Follow this CEO

Get an email the morning Sveinn Sölvason’s card turns.

One email when the stamp changes or a new promise is checked. Nothing else.

Your choices
Your editions
How often
Breaking Briefs

Next: read today’s Morning Brief →